Dss, inc. celebrates impact biomedical inc.'s successful ipo and proudly advances shareholder value

New york, sept. 16, 2024 (globe newswire) -- dss, inc. (nyse american: dss), a dedicated supporter and investor in impact biomedical inc. (nyse american: ibo), is delighted to announce the successful pricing of impact biomedical's initial public offering (ipo). impact biomedical, a trailblazer in advancing human healthcare and wellness solutions, has set its ipo price at $3.00 per share, with an initial offering of 1,500,000 shares. trading under the ticker symbol “ibo,” these shares will begin trading on the nyse american market on september 16, 2024.
DSS Ratings Summary
DSS Quant Ranking